ArticleOncology letters2020

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.

Zhangyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.